S&P 500   3,896.58 (+2.24%)
DOW   31,556.66 (+2.02%)
QQQ   322.13 (+2.54%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
S&P 500   3,896.58 (+2.24%)
DOW   31,556.66 (+2.02%)
QQQ   322.13 (+2.54%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
S&P 500   3,896.58 (+2.24%)
DOW   31,556.66 (+2.02%)
QQQ   322.13 (+2.54%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
S&P 500   3,896.58 (+2.24%)
DOW   31,556.66 (+2.02%)
QQQ   322.13 (+2.54%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
Log in
NASDAQ:ATRA

Atara Biotherapeutics Short Interest Ratio and Short Volume

$17.28
+0.50 (+2.98 %)
(As of 03/1/2021 12:02 PM ET)
Add
Compare
Today's Range
$17.07
Now: $17.28
$17.46
50-Day Range
$16.61
MA: $18.89
$20.72
52-Week Range
$4.52
Now: $17.28
$28.20
Volume5,343 shs
Average Volume839,795 shs
Market Capitalization$1.34 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.65

Short Interest

Atara Biotherapeutics (NASDAQ:ATRA) Short Interest Data

Current Short Volume11,740,000 shares
Previous Short Volume11,820,000 shares
Change Vs. Previous Month:-0.68%
Dollar Volume Sold Short$197.00 million
Short Interest Ratio / Days to Cover12.4
Last Record DateFebruary, 12 2021
Outstanding Shares53,190,000 shares
Percentage of Shares Shorted15.11%
Today's Trading Volume5,343 shares
Average Trading Volume839,795 shares
Today's Volume Vs. Average-99.36%

Short Interest Over Time


Atara Biotherapeutics (NASDAQ:ATRA) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/202111,740,000 shares $197.00 million -0.7%N/A12.4 $16.78
1/29/202111,820,000 shares $228.84 million +5.0%N/A11.7 $19.36
1/15/202111,260,000 shares $213.94 million -6.1%N/A11.6 $19.00
12/31/202012,460,000 shares $247.95 million +1.0%N/A14.2 $19.90
12/15/202012,460,000 shares $239.98 million +1.0%N/A14.2 $19.26
11/30/202012,340,000 shares $267.16 million -10.1%N/A13.5 $21.65
11/15/202013,730,000 shares $318.40 million -10.3%N/A16.4 $23.19
10/30/202015,310,000 shares $276.35 million -0.8%N/A19.7 $18.05
10/15/202015,440,000 shares $218.17 million +9.0%N/A19.1 $14.13
9/30/202014,170,000 shares $200.08 million +3.3%N/A17.4 $14.12
9/15/202013,720,000 shares $177.95 million -10.1%N/A12.9 $12.97
8/31/202015,260,000 shares $236.99 million +4.5%N/A14.3 $15.53
8/14/202014,610,000 shares $189.20 million +3.5%N/A11 $12.95
7/31/202014,110,000 shares $174.96 million -4.3%N/A8.9 $12.40
7/15/202014,740,000 shares $182.63 million +8.7%N/A9.1 $12.39
6/30/202013,560,000 shares $187.26 million +15.7%N/A7.9 $13.81
6/15/202011,720,000 shares $176.97 million -1.3%N/A7.7 $15.10
5/29/202011,870,000 shares $153.36 million -5.4%N/A8.4 $12.92
5/15/202012,550,000 shares $144.33 million +4.8%23.9%9.8 $11.50
4/30/202011,980,000 shares $133.34 million +17.1%22.8%14 $11.13
4/15/202010,230,000 shares $104.86 million +3.9%19.5%13 $10.25
3/31/20209,850,000 shares $87.27 million +1.1%18.9%14.4 $8.86
3/13/20209,745,100 shares $83.32 million -0.8%25.2%16.6 $8.55
2/28/20209,820,000 shares $77.48 million +5.4%25.3%15 $7.89
2/14/20209,320,000 shares $100.38 million -2.2%19.4%14.4 $10.77

Atara Biotherapeutics (NASDAQ:ATRA) Short Interest FAQ

speech bubbles
speech bubbles











What is Atara Biotherapeutics' current short interest?

Short interest is the volume of Atara Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, traders have sold 11,740,000 shares of ATRA short.

What is a good short interest ratio for Atara Biotherapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Atara Biotherapeutics currently has a short interest ratio of 12.0.

Is Atara Biotherapeutics' short interest increasing or decreasing?

Atara Biotherapeutics saw a decrease in short interest in February. As of February 12th, there was short interest totaling 11,740,000 shares, a decrease of 0.7% from the previous total of 11,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Atara Biotherapeutics' short interest compare to its competitors?

0.00% of Atara Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Atara Biotherapeutics: Beam Therapeutics Inc. (16.38%), Allogene Therapeutics, Inc. (15.84%), China Biologic Products Holdings, Inc. (5.58%), SpringWorks Therapeutics, Inc. (9.00%), Relay Therapeutics, Inc. (11.86%), NantKwest, Inc. (15.59%), NanoString Technologies, Inc. (0.00%), Revolution Medicines, Inc. (11.25%), Editas Medicine, Inc. (0.00%), and Sorrento Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Atara Biotherapeutics stock?

Short selling ATRA is an investing strategy that aims to generate trading profit from Atara Biotherapeutics as its price is falling. Atara Biotherapeutics' stock is trading up $0.50 today. To short Atara Biotherapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Atara Biotherapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Atara Biotherapeutics?

A short squeeze for Atara Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRA, which in turn drives the price of the stock up even further.

How often is Atara Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRA, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.